Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer

Cancer Letters

Volumn 274, Issue 2, 2009, Pages 225-232

  Ko, Eunkyung ^a   Kim, Yujin ^a   Lee, Bo Bin ^a   Han, Joungho ^a   Song, Sang Yong ^a   Shim, Young Mog ^a   Park, Joobae ^a,b   Kim, Duk Hwan ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Cyclin D1; Non small cell lung cancer; p16; Phosphorylation; pRb; Smoking

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN; TOBACCO SMOKE;

ADULT; ARTICLE; CANCER PATIENT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOKING;

CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; SERINE; SMOKE; TOBACCO;

NICOTIANA TABACUM;

EID: 58149316237     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.016     Document Type: Article

References (35)

1. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
2. Wistuba I.I., Gazdar A.F., and Minna J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28 (2001) 3-13
3. Burke L., Flieder D.B., Guinee D.G., Brambilla E., Freedman A.N., Bennett W.P., Jones R.T., Borkowski A., Caporaso N.A., Fleming M., Trastek V., Pairolero P., Tazelaar H., Midthun D., Jett J.R., Liotta L.A., Travis W.D., and Harris C.C. Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin. Cancer Res. 11 (2005) 232-241
4. Mittnacht S. Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8 (1998) 21-27
5. Yamanouchi H., Furihata M., Fujita J., Murakami H., Yoshinouchi T., Takahara J., and Ohtsuki Y. Expression of cyclin E and cyclin D1 in non-small cell lung cancers. Lung Cancer 31 (2001) 3-8
6. Esposito V., Baldi A., De Luca A., Tonini G., Vincenzi B., Santini D., Persichetti P., Mancini A., Citro G., Baldi F., Groeger A.M., and Caputi M. Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J. Clin. Pathol. 58 (2005) 734-739
7. Yuan J., Knorr J., Altmannsberger M., Goeckenjan G., Ahr A., Scharl A., and Strebhardt K. Expression of p16 and lack of pRB in primary small cell lung cancer. J. Pathol. 189 (1999) 358-362
8. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12 (1998) 2245-2262
9. Yang R., Müller C., Huynh V., Fung Y.K., Yee A.S., and Koeffler H.P. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins. Mol. Cell. Biol. 19 (1999) 2400-2407
10. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G 1 cyclin dependent kinases. Genes Dev. 9 (1995) 1149-1163
11. Serrano M., Hannon G.J., and Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
12. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., Stockert E., Day R.S., Johnson B.E., and Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 (1994) 436-440
13. Geradts J., Fong K.M., Zimmerman P.V., Maynard R., and Minna J.D. Correlation of abnormal RB p16ink4a and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin. Cancer Res. 5 (1999) 791-800
14. Zöchbauer-Müller S., Fong K.M., Virmani A.K., Geradts J., Gazdar A.F., and Minna J.D. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61 (2001) 249-255
15. Kim D.-H., Nelson H.H., Wiencke J.K., Zheng S., Christiani D.C., Wain J.C., Mark E.J., and Kelsey K.T. p16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 61 (2001) 3419-3424
16. Herman J.D., Graff J.R., Myöhänen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93 (1996) 9821-9826
17. Toyooka S., Suzuki M., Tsuda T., Toyooka K.O., Maruyama R., Tsukuda K., Fukuyama Y., Iizasa T., Fujisawa T., Shimizu N., Minna J.D., and Gazdar A.F. Dose effect of smoking on aberrant methylation in non-small cell lung cancers. Int. J. Cancer 110 (2004) 462-464
18. Belinsky S.A., Nikula K.J., Palmisano W.A., Michels R., Saccomanno G., Gabrielson E., Baylin S.B., and Herman J.G. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. USA 95 (1998) 11891-11896
19. Divine K.K., Pulling L.C., Marron-Terada P.G., Liechty K.C., Kang T., Schwartz A.G., Bocklage T.J., Coons T.A., Gilliland F.D., and Belinsky S.A. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers. Int. J. Cancer 114 (2005) 400-405
20. Zhong C.Y., Zhou Y.M., Douglas G.C., Witschi H., and Pinkerton K. E, MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26 (2005) 2187-2195
21. Ho Y.S., Chen C.H., Wang Y.J., Pestell R.G., Albanese C., Chen R.J., Chang M.C., Jeng J.H., Lin S.Y., Liang Y.C., Tseng H., Lee W.S., Lin J.K., Chu J.S., Chen L.C., Lee C.H., Tso W.L., Lai Y.C., and Wu C.H. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol. Appl. Pharmacol. 205 (2005) 133-148
22. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., Zhang C., Gills J.J., Sayyah J., and Dennis P.A. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. Carcinogenesis 26 (2005) 1182-1195
23. Ratschiller D., Heighway J., Gugger M., Kappeler A., Pirnia F., Schmid R.A., Borner M.M., and Betticher D.C. Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J. Clin. Oncol. 21 (2003) 2085-2093
24. Volm M., and Koomägi R. Association of cyclin D1 expression in lung cancer and the smoking habits of patients. Cancer Lett. 141 (1999) 147-150
25. Mishina T., Dosaka-Akita H., Hommura F., Nishi M., Kojima T., Ogura S., Shimizu M., Katoh H., and Kawakami Y. Cyclin E expression a potential prognostic marker for non-small cell lung cancers. Clin. Cancer Res. 6 (2000) 11-16
26. Dobashi Y., Shoji M., Jiang S.X., Kobayashi M., Kawakubo Y., and Kameya T. Active cyclin A-CDK2 complex a possible critical factor for cell proliferation in human primary lung carcinomas. Am. J. Pathol. 153 (1998) 963-972
27. Lundberg A.S., and Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18 (1998) 753-761
28. Lukas J., Herzinger T., Hansen K., Moroni M.C., Resnitzky D., Helin K., Reed S.I., and Bartek J. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11 (1997) 1479-1492
29. Geng Y., Whoriskey W., Park M.Y., Bronson R.T., Medema R.H., Li T., Weinberg R.A., and Sicinski P. Rescue of cyclin D1 deficiency by knockin of cyclin E. Cell 97 (1999) 767-777
30. Rubin E., Tamrakar S., and Ludlow J.W. Protein phosphatase type 1 the product of the retinoblastoma susceptibility gene and cell cycle control. Front. Biosci. 3 (1998) 1209-1219
31. Lees J.A., Buchkovich K.J., Marshak D.R., Anderson C.W., and Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10 (1991) 4279-4290
32. Kitagawa M., Higashi H., Jung H.K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S., and Taya Y. The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclinA/E-cdk2. EMBO J. 15 (1996) 7060-7069
33. Connell-Crowley L., Harper J.W., and Goodrich D.W. Cyclin D1/cdk4 regulates retinblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8 (1997) 287-301
34. Zarkowska T., and Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272 (1997) 12738-12746
35. Mandell J.W. Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology. Am. J. Pathol. 163 (2003) 1687-1698